** Shares of CompuGroup Medical COP1n.DE drop 8.7% after
the German medical software company cut FY outlook due to
project postponements into 2023
** The company now expects adjusted EBITDA of 220-240
million euros and free cash flow of 40-70 million euros vs
previous forecast of 240-260 million and over 100 million,
respectively
** "We expect a strong negative share price reaction, as
management confirmed FY guidance during the September CMD,"
Jefferies says
** Baader Helvea expresses no concerns about the guidance
cut, but says it will likely be taken as a negative by the
market
($1 = 1.0051 euros)
(Reporting by Anastasiia Kozlova)
((Anastasiia.Kozlova@thomsonreuters.com))